Bright Minds Biosciences Inc. Made Headway
Wed, Apr 19, 2023 at 07:03 PM
Bright Minds Biosciences Inc. (DRUG:NASDAQ) soared at $0.73, a gain of 31.5%. On Wed, Apr 19, 2023, DRUG:NASDAQ hit a New 2-Week High of $0.73. The stock appeared on our News Catalysts scanner on Mon, Apr 10, 2023 at 08:32 AM in the 'MISCELLANEOUS' category. From Wed, Apr 05, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Tue, Apr 18, 2023 at $0.85 with a volume of 24M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 80.62%
- BIOLASE, Inc. (BIOL:NASDAQ), 43.73%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 39.94%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 38.61%
- Bed Bath & Beyond Inc. (BBBY:NASDAQ), 34.46%
- SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 33.47%
- Getaround Inc. (GETR:NYSE), 32.2%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 31.5%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSE), 29.51%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 29.11%